Analysis of Trial Data for Infliximab and Golimumab: Baseline C‐Reactive Protein Level and Prediction of Therapeutic Response in Patients With Psoriatic Arthritis

Publisher: John Wiley & Sons Inc

E-ISSN: 2151-4658|66|7|1114-1118

ISSN: 2151-464x

Source: ARTHRITIS CARE AND RESEARCH, Vol.66, Iss.7, 2014-07, pp. : 1114-1118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content